Immunohistochemical (IHC) analysis of the tumor tissues further confirmed the downregulation of Ki67 expression, a marker of cell proliferation, in tumors derived from the shALDOC group, validating the efficacy of ALDOC knockdown in the tumor tissues (Fig. 3D). Here, ALDOC is linked to neoplasm.